# Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

> **NCT07177612** · — · ENROLLING_BY_INVITATION · sponsor: **Changi General Hospital** · enrollment: 20000 (estimated)

## Conditions studied

- Lipoprotein(a)
- Lipoprotein(a), Hyper-Lp(a)-Emia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07177612
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-09
- **Primary completion:** 2028-08
- **Final completion:** 2028-12
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07177612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07177612, "Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07177612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*